Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Endocrine Gland Neoplasms (D004701)
Parent Node:
expand
Head and Neck Neoplasms (D006258)
Parent Node:
expand
Parathyroid Diseases (D010279)
..Starting node
..expand
Parathyroid Neoplasms (D010282)

       Child Nodes:
........expandParathyroid cancer, adult (C537173)



 Sister Nodes: 
..expandHyperparathyroidism (D006961) Child12
..expandHypoparathyroidism (D007011) Child14
..expandParathyroid Neoplasms (D010282) Child1
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:8637
Name:Parathyroid Neoplasms
Definition:Tumors or cancer of the PARATHYROID GLANDS.
Alternative IDs:OMIM:608266
ParentIDs:MESH:D004701|MESH:D006258|MESH:D010279
TreeNumbers:C04.588.322.525 |C04.588.443.680 |C19.344.525 |C19.642.713
Synonyms:Adenoma, Parathyroid |Adenomas, Parathyroid |Cancer of Parathyroid |Cancer of the Parathyroid |Cancer, Parathyroid |Cancers, Parathyroid |Carcinoma, Parathyroid |Carcinomas, Parathyroid |Neoplasm, Parathyroid |Neoplasms, Parathyroid |Parathyroid Adenoma |Parathyroi
Slim Mappings:Cancer|Endocrine system disease
Reference: MedGen: D010282
MeSH: D010282
OMIM: 608266;

Genes: CDC73;
Phenotypes
1 HP:0000006Autosomal dominant inheritance
2 HP:0003072Hypercalcemia
3 HP:0000843Hyperparathyroidism
4 HP:0006780Parathyroid carcinoma
5 HP:0001428Somatic mutation
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_024529.4(CDC73):c.-11G>A79577CDC73Benign80356643RCV000020878; NMedGen:C0687150,OMIM:608266,ORPHA:143,SNOMED CT:2550370041193091320193091320NM_024529.4:c.-11G>ANC_000001.10:g.193091320G>A-C0687150 608266 Parathyroid carcinoma
NM_024529.4(CDC73):c.13_30del18 (p.Leu5_Gln10del)79577CDC73Pathogenic587776561RCV000003442; NMedGen:C0687150,OMIM:608266,ORPHA:143,SNOMED CT:2550370041193091343193091360NM_024529.4:c.13_30del18NP_078805.3:p.Leu5_Gln10delOMIM Allelic Variant:607393.0015C0687150 608266 Parathyroid carcinoma
NM_024529.4(CDC73):c.85delG (p.Glu29Serfs)79577CDC73Pathogenic587776560RCV000003441; NMedGen:C0687150,OMIM:608266,ORPHA:143,SNOMED CT:2550370041193091415193091415NM_024529.4:c.85delGNP_078805.3:p.Glu29SerfsOMIM Allelic Variant:607393.0014C0687150 608266 Parathyroid carcinoma
NM_024529.4(CDC73):c.128G>A (p.Trp43Ter)79577CDC73Pathogenic121434263RCV000003430; NMedGen:C0687150,OMIM:608266,ORPHA:143,SNOMED CT:2550370041193091458193091458NM_024529.4:c.128G>ANP_078805.3:p.Trp43TerNC_000001.10:g.193091458G>AOMIM Allelic Variant:607393.0005C0687150 608266 Parathyroid carcinoma
NM_024529.4(CDC73):c.162C>G (p.Tyr54Ter)79577CDC73Pathogenic121434265RCV000003433; NMedGen:C0687150,OMIM:608266,ORPHA:143,SNOMED CT:2550370041193094272193094272NM_024529.4:c.162C>GNP_078805.3:p.Tyr54TerNC_000001.10:g.193094272C>GOMIM Allelic Variant:607393.0008C0687150 608266 Parathyroid carcinoma
NM_024529.4(CDC73):c.237+28T=79577CDC73Benign4466634RCV000020881; NMedGen:C0687150,OMIM:608266,ORPHA:143,SNOMED CT:2550370041193094375193094375NM_024529.4:c.237+28T=NC_000001.10:g.193094375Tx3d-C0687150 608266 Parathyroid carcinoma
NM_024529.4(CDC73):c.237+28_237+31delTCTA79577CDC73Benign80356645RCV000020882; NMedGen:C0687150,OMIM:608266,ORPHA:143,SNOMED CT:2550370041193094375193094378NM_024529.4:c.237+28_237+31delTCTANC_000001.10:g.193094375_193094378delTCTA-C0687150 608266 Parathyroid carcinoma
NM_024529.4(CDC73):c.679_680insAG (p.Arg227Lysfs)79577CDC73Pathogenic80356649RCV000003427; RCV000003428; RCV000003429; NMedGen:C0687150,OMIM:608266,ORPHA:143,SNOMED CT:255037004; MedGen:C1704981,OMIM:145001,ORPHA:99880; MedGen:C1840402,OMIM:1450001193111146193111147NM_024529.4:c.679_680insAGNP_078805.3:p.Arg227LysfsNC_000001.10:g.193111146_193111147insAGOMIM Allelic Variant:607393.0004C1840402 145000 Hyperparathyroidism 1; C1704981 145001 Hyperparathyroidism 2; C0687150 608266 Parathyroid carcinoma
NM_024529.4(CDC73):c.729+50_729+51delAG79577CDC73Benign80356646RCV000020884; NMedGen:C0687150,OMIM:608266,ORPHA:143,SNOMED CT:2550370041193111246193111247NM_024529.4:c.729+50_729+51delAGNC_000001.10:g.193111246_193111247delAG-C0687150 608266 Parathyroid carcinoma
NM_024529.4(CDC73):c.766_767delGT (p.Val256Lysfs)79577CDC73Pathogenic80356650RCV000020885; NMedGen:C0687150,OMIM:608266,ORPHA:143,SNOMED CT:2550370041193117033193117034NM_024529.4:c.766_767delGTNP_078805.3:p.Val256LysfsNC_000001.10:g.193117033_193117034delGT-C0687150 608266 Parathyroid carcinoma
NM_024529.4(CDC73):c.1066+8T>C79577CDC73Benign;Likely benign80356647RCV000211486; RCV000020879; NMedGen:C0687150,OMIM:608266,ORPHA:143,SNOMED CT:255037004; MedGen:C1704981,OMIM:145001,ORPHA:998801193181238193181238NM_024529.4:c.1066+8T>CNC_000001.10:g.193181238T>C-C1704981 145001 Hyperparathyroidism 2; C0687150 608266 Parathyroid carcinoma
NM_024529.4(CDC73):c.1418-17C>G79577CDC73Benign11583414RCV000020880; NMedGen:C0687150,OMIM:608266,ORPHA:143,SNOMED CT:2550370041193218843193218843NM_024529.4:c.1418-17C>GNC_000001.10:g.193218843C>G-C0687150 608266 Parathyroid carcinoma
NM_024529.4(CDC73):c.*12C>A79577CDC73Likely benign193025205RCV000206613; NMedGen:C0687150,OMIM:608266,ORPHA:143,SNOMED CT:2550370041193219854193219854NM_024529.4:c.*12C>ANC_000001.10:g.193219854C>A-C0687150 608266 Parathyroid carcinoma